The effects of Saccharomyces boulardii on TLR4/NF-κB neuroinflammatory pathway in the hippocampus of LPS-induced rats
Masoume Akhbari, Fatemeh Babaei, Ava Navidi-Moghaddam, Shiva Ghafghazi, Fatemeh Khodabandehloo, Mohammad Reza Sarookhani, Leila Dargahi, Ghazaleh Mohammadi, Marjan Nassiri-Asl · 2026
Read The effects of Saccharomyces boulardii on TLR4/NF-κB neuroinflammatory pathway in the hippocampus of LPS-induced rats by Masoume Akhbari, Fatemeh Babaei, Ava Navidi-Moghaddam, Shiva Ghafghazi, Fatemeh Khodabandehloo, Mohammad Reza Sarookhani, Leila Dargahi, Ghazaleh Mohammadi, Marjan Nassiri-Asl (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/PMC13342975.txt.
Description
Masoume Akhbari and co-authors test a probiotic yeast in rats in 2026, asking whether it can calm brain inflammation tied to Alzheimer's disease pathways. The yeast, Saccharomyces boulardii, acts through the gut-brain axis, and the team targeted the TLR4 and NF-κB signaling route in the hippocampus after injections of bacterial toxin.
Four groups of rats received the yeast, the toxin, both, or neither over four weeks. Yeast pretreatment partly protected spatial memory, lowered raised NF-κB and IL-1β levels, and saved neurons in the CA1 region from loss. The effect ran through downstream steps of the pathway rather than the receptor itself, hinting at gut-based routes to ease brain inflammation.
Catalog record
| CREATOR | Masoume Akhbari, Fatemeh Babaei, Ava Navidi-Moghaddam, Shiva Ghafghazi, Fatemeh Khodabandehloo, Mohammad Reza Sarookhani, Leila Dargahi, Ghazaleh Mohammadi, Marjan Nassiri-Asl |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 30639 |
| LICENSE | https://creativecommons.org/licenses/by/4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |